Here are the S-1 registration statements from VSEE HEALTH INC (VSEE) in our archive over the last 12 months, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
An S-1 covers the registration statement a company files to sell shares publicly, so if you follow VSEE and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full VSEE filings page.
VSee Health, Inc. registered up to 3,540,000 common shares for resale by ClearThink Capital Partners, LLC: 40,000 commitment-fee shares already issued and up to 3,500,000 shares VSee may issue and sell to ClearThink under the Strata Agreement. VSee receives no proceeds from ClearThink’s resales, but may receive proceeds from separate sales to ClearThink; ClearThink committed to purchase up to $5.0 million of shares, subject to the agreement’s conditions.
Under the Strata Agreement, VSee may direct purchases over an approximately 36-month period beginning after the resale registration statement is declared effective and remains effective, subject to the agreement’s conditions. The purchase price is 85% of the lowest daily closing price during the 10 trading days preceding the purchase date. VSee may not direct purchases that would put ClearThink and its affiliates’ beneficial ownership above 9.99% of outstanding common stock. VSee expects any proceeds from its sales to be used for working capital and general corporate purposes.
The auditor identified material weaknesses in financial reporting controls for the year ended December 31, 2025. Management concluded substantial doubt exists about VSee’s ability to continue as a going concern for one year after the financial statements were issued. Operating cash outflows were $3,625,916 for the six months ended June 30, 2026.